Oxford University Press

SHERPA: Yellow

People

  1. Karajannis
    Karajannis
  2. Abou-Alfa
    Abou-Alfa
  3. Motzer
    Motzer
  4. Kramer
    Kramer
  5. Rosenberg
    Rosenberg
  6. De Angelis
    De Angelis
  7. Autio
    Autio
  8. Donzelli
    Donzelli
  9. Drilon
    Drilon
  10. Dunkel
    Dunkel

Groups

  1. Department of Medicine (145)
  2. Solid Tumor Oncology Division (126)
  3. GSK Faculty (45)
  4. Genitourinary Oncology Service (40)
  5. Survivorship Research (40)
  6. Pediatrics, Department of (37)
  7. Gastrointestinal Oncology Service (32)
  8. Neuro-Oncology Service (29)
  9. Radiology, Department of (22)
  10. Sloan Kettering Institute Postdocs (22)
Search Within
  1. "2018"
Formats
  1. Meeting Abstract (183)
  2. Journal Article (81)
Groups
  1. Department of Medicine (145)
  2. Solid Tumor Oncology Division (126)
  3. GSK Faculty (45)
  4. Genitourinary Oncology Service (40)
  5. Survivorship Research (40)
  6. Pediatrics, Department of (37)

More Groups

People
  1. Matthias Karajannis (12)
  2. Ghassan Abou-Alfa (10)
  3. Robert Motzer (10)
  4. Jonathan Rosenberg (9)
  5. Kim Kramer (9)
  6. Lisa De Angelis (8)

More People

Years
  1. 2018 (264)
Publications
  1. Annals of Oncology (140)
  2. Neuro-Oncology (73)
  3. JNCI: Journal of the National Cancer Institute (7)
  4. American Journal of Clinical Pathology (6)
  5. Journal of Neuropathology and Experimental Neurology (5)
  6. Clinical Infectious Diseases (4)

More Publications

Results (264)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updates on the phase II and re-treatment study of AZD6244 (selumetinib) for children with recurrent or refractory pediatric low grade glioma: A Pediatric Brain Tumor Consortium (PBTC) Study
    Meeting Abstract

    Fangusaro, J. R.; Onar-Thomas, A.; Poussaint, T. Y.; Wu, S. J.; Ligon, A. H.; Lindeman, N. I.; Banerjee, A.; Packer, R.; Kilburn, L. B.; Pollack, I. F.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Relationship between anthropometric factors and risk of second breast cancer among women with a history of ductal carcinoma in situ
    Journal Article

    Flanagan, M. R.; Tang, M. T. C.; Baglia, M. L.; Porter, P. L.; Malone, K. E.; Li, C. I.
    JNCI Cancer Spectrum (2018)

    Fulltext@MSK | Save
  • Grain intake and clinical outcome in stage III colon cancer: Results from CALGB 89803 (Alliance)
    Journal Article

    Brown, J. C.; Zhang, S.; Niedzwiecki, D.; Saltz, L. B.; Mayer, R. J.; Mowat, R. B.; Whittom, R.; Hantel, A.; Benson, A.; Atienza, D.; more...
    JNCI Cancer Spectrum (2018)

    Fulltext@MSK | Save
  • Selecting patients with triple negative breast cancer for platinum-based therapy: We still haven't found what we're looking for
    Journal Article

    Robson, M.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Surrogate end points in lymphoma
    Journal Article

    Batlevi, C. L.; Younes, A.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
    Meeting Abstract

    Wang, Y.; Yang, J.; Wu, W.; Shah, R.; Danussi, C.; Riggins, G.; Kannan, K.; Sulman, E.; Chan, T.; Huse, J.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Precise investigation of cancer stem cells in a mouse glioblastoma model
    Meeting Abstract

    Xie, X.; Laks, D.; Sun, D.; Poran, A.; Laughney, A.; Belenguer, G.; Massague, J.; Zhou, X.; Farinas, I.; Elemento, O.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Prospective evaluation of cerebrospinal fluid circulating tumor cells (CSF CTC) in patients with HER2 positive cancers and leptomeningeal metastases receiving treatment with intrathecal trastuzumab
    Meeting Abstract

    Pentsova, E.; Malani, R.; Fleisher, M.; Lin, X.; Omuro, A.; Groves, M.; Lin, N.; Melisko, M.; Lassman, A.; Jeyapalan, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma
    Meeting Abstract

    Lacouture, M.; Hershkovich, H.; Giladi, M.; Blat, R.; Bomzon, Z.; Kirson, E.; Weinberg, U.; Palti, Y.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Genomic attributes of tumor evolution and treatment response in diffuse glioma
    Meeting Abstract

    Lin, A. L.; Jonsson, P.; Ogilvie, S.; Chavan, S.; Nolan, C.; Gavrilovic, I.; Kaley, T.; Grommes, C.; Pentsova, E.; Diamond, E.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save